1. Home
  2. SION vs CTBI Comparison

SION vs CTBI Comparison

Compare SION & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • CTBI
  • Stock Information
  • Founded
  • SION 2019
  • CTBI 1903
  • Country
  • SION United States
  • CTBI United States
  • Employees
  • SION N/A
  • CTBI N/A
  • Industry
  • SION
  • CTBI Major Banks
  • Sector
  • SION
  • CTBI Finance
  • Exchange
  • SION NYSE
  • CTBI Nasdaq
  • Market Cap
  • SION 871.7M
  • CTBI 1.0B
  • IPO Year
  • SION 2025
  • CTBI N/A
  • Fundamental
  • Price
  • SION $16.92
  • CTBI $53.11
  • Analyst Decision
  • SION Strong Buy
  • CTBI Buy
  • Analyst Count
  • SION 1
  • CTBI 3
  • Target Price
  • SION $32.00
  • CTBI $59.00
  • AVG Volume (30 Days)
  • SION 136.3K
  • CTBI 52.3K
  • Earning Date
  • SION 08-25-2025
  • CTBI 07-16-2025
  • Dividend Yield
  • SION N/A
  • CTBI 3.54%
  • EPS Growth
  • SION N/A
  • CTBI 17.47
  • EPS
  • SION N/A
  • CTBI 5.08
  • Revenue
  • SION N/A
  • CTBI $253,839,000.00
  • Revenue This Year
  • SION N/A
  • CTBI $20.63
  • Revenue Next Year
  • SION N/A
  • CTBI $4.63
  • P/E Ratio
  • SION N/A
  • CTBI $10.46
  • Revenue Growth
  • SION N/A
  • CTBI 12.25
  • 52 Week Low
  • SION $7.26
  • CTBI $44.60
  • 52 Week High
  • SION $25.19
  • CTBI $61.67
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • CTBI 40.03
  • Support Level
  • SION N/A
  • CTBI $55.05
  • Resistance Level
  • SION N/A
  • CTBI $56.33
  • Average True Range (ATR)
  • SION 0.00
  • CTBI 1.32
  • MACD
  • SION 0.00
  • CTBI -0.47
  • Stochastic Oscillator
  • SION 0.00
  • CTBI 9.51

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: